Skip to main content
Top
Published in: Pediatric Nephrology 6/2011

01-06-2011 | Original Article

Protective effects of Huang Qi Huai granules on adriamycin nephrosis in rats

Authors: Chunhua Zhu, Songming Huang, Guixia Ding, Yanggang Yuan, Qiuxia Chen, Xiaoqin Pan, Ronghua Chen, Aihua Zhang

Published in: Pediatric Nephrology | Issue 6/2011

Login to get access

Abstract

Huang Qi Huai (HQH) granules, a mixture of Chinese herbs, contains trametes robiniophila murr, wolfberry fruit, and Polygonatum. We investigated the mechanism of the protective effects of HQH on adriamycin nephrosis (ADR) in rats. Adriamycin nephrotic rats were induced by a single dose of 5 mg/kg adriamycin. For the HQH-treated adriamycin nephrosis group, 1 day after treatment with 5 mg/kg adriamycin, the rats were administered once-daily oral gavage of 2 mg/kg HQH for 15 days. All the rats were killed at day 15. Histological changes were observed by light microscopy and transmission electron microscope. Nephrin and podocin expression levels were measured by real-time RT-PCR and Western blot. Proteinuria was measured by the Bradford protein assay. Serum TNF-α and IL-1β levels were evaluated by ELISA. Macrophage infiltration was detected by immunohistochemistry and immunoblotting, respectively. ADR rats showed heavy proteinuria, podocyte and tubulointerstitial injury, macrophage infiltration, and increased levels of serum cytokines TNF-α and IL-1β. HQH significantly ameliorated the adriamycin-induced renal injury. These data were validated in the cultured podocytes. The podocytes were treated by adriamycin in the presence or absence of HQH and nephrin and podocin expression and TNF-α and IL-1β synthesis and secretion were determined by real-time RT-PCR, immunoblotting, and ELISA, respectively. Adriamycin significantly reduced nephrin and podocin expression, which was significantly restored by the treatment of HQH. HQH treatment inhibited adriamycin-induced TNF-α and IL-1β expression. Our findings suggest that HQH significantly reduces proteinuria, prevents podocyte injury, and ameliorates tubulointerstitial damage. Inhibition of inflammatory cytokine expression and macrophage infiltration may be the protective mechanism of HQH.
Literature
1.
go back to reference Eddy AA, Symons JM (2003) Nephrotic syndrome in childhood. Lancet 362:629–639CrossRef Eddy AA, Symons JM (2003) Nephrotic syndrome in childhood. Lancet 362:629–639CrossRef
2.
go back to reference Araya CE, Wasserfall CH, Brusko TM, Mu W, Segal MS, Johnson RJ, Garin EH (2006) A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome. Pediatr Nephrol 21:603–610CrossRef Araya CE, Wasserfall CH, Brusko TM, Mu W, Segal MS, Johnson RJ, Garin EH (2006) A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome. Pediatr Nephrol 21:603–610CrossRef
3.
go back to reference Huang Q (2004) Observation of curative effect on 62 cases of repeated respiratory tract infection of cerebral palsy by Huan Er Jin-Huai Ji Huang Ke Li. J Henan University Chin Med 19:65–65 Huang Q (2004) Observation of curative effect on 62 cases of repeated respiratory tract infection of cerebral palsy by Huan Er Jin-Huai Ji Huang Ke Li. J Henan University Chin Med 19:65–65
4.
go back to reference Wang C (2007) Preventive and curative effect of Huan Erjin on children's repeated respiratory tract infection. China Pharmacist 10:1026–1027 Wang C (2007) Preventive and curative effect of Huan Erjin on children's repeated respiratory tract infection. China Pharmacist 10:1026–1027
5.
go back to reference Takahashi S, Wada N, Murakami H, Funaki S, Inagaki T, Harada K, Nagata M (2007) Triggers of relapse in steroid-dependent and frequently relapsing nephrotic syndrome. Pediatr Nephrol 22:232–236CrossRef Takahashi S, Wada N, Murakami H, Funaki S, Inagaki T, Harada K, Nagata M (2007) Triggers of relapse in steroid-dependent and frequently relapsing nephrotic syndrome. Pediatr Nephrol 22:232–236CrossRef
6.
go back to reference Abeyagunawardena AS, Trompeter RS (2008) Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomised controlled trial. Arch Dis Child 93:226–228CrossRef Abeyagunawardena AS, Trompeter RS (2008) Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomised controlled trial. Arch Dis Child 93:226–228CrossRef
7.
go back to reference Turnberg D, Lewis M, Moss J, Xu Y, Botto M, Cook HT (2006) Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice. J Immunol 177:4094–4102CrossRef Turnberg D, Lewis M, Moss J, Xu Y, Botto M, Cook HT (2006) Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice. J Immunol 177:4094–4102CrossRef
8.
go back to reference Wang SN, Hirschberg R (1999) Tubular epithelial cell activation and interstitial fibrosis. The role of glomerular ultrafiltration of growth factors in the nephrotic syndrome and diabetic nephropathy. Nephrol Dial Transplant 14:2072–2074CrossRef Wang SN, Hirschberg R (1999) Tubular epithelial cell activation and interstitial fibrosis. The role of glomerular ultrafiltration of growth factors in the nephrotic syndrome and diabetic nephropathy. Nephrol Dial Transplant 14:2072–2074CrossRef
9.
go back to reference Marshall SM (2007) The podocyte: a potential therapeutic target in diabetic nephropathy? Curr Pharm Des 13:2713–2720CrossRef Marshall SM (2007) The podocyte: a potential therapeutic target in diabetic nephropathy? Curr Pharm Des 13:2713–2720CrossRef
10.
go back to reference Sean Eardley K, Cockwell P (2005) Macrophages and progressive tubulointerstitial disease. Kidney Int 68:437–455CrossRef Sean Eardley K, Cockwell P (2005) Macrophages and progressive tubulointerstitial disease. Kidney Int 68:437–455CrossRef
11.
go back to reference Khan SB, Cook HT, Bhangal G, Smith J, Tam FW, Pusey CD (2005) Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis. Kidney Int 67:1812–1820CrossRef Khan SB, Cook HT, Bhangal G, Smith J, Tam FW, Pusey CD (2005) Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis. Kidney Int 67:1812–1820CrossRef
12.
go back to reference Takano Y, Yamauchi K, Hayakawa K, Hiramatsu N, Kasai A, Okamura M, Yokouchi M, Shitamura A, Yao J, Kitamura M (2007) Transcriptional suppression of nephrin in podocytes by macrophages: roles of inflammatory cytokines and involvement of the PI3K/Akt pathway. FEBS Lett 581:421–426CrossRef Takano Y, Yamauchi K, Hayakawa K, Hiramatsu N, Kasai A, Okamura M, Yokouchi M, Shitamura A, Yao J, Kitamura M (2007) Transcriptional suppression of nephrin in podocytes by macrophages: roles of inflammatory cytokines and involvement of the PI3K/Akt pathway. FEBS Lett 581:421–426CrossRef
13.
go back to reference Tang WW, Feng L, Vannice JL, Wilson CB (1994) Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis. J Clin Invest 93:273–279CrossRef Tang WW, Feng L, Vannice JL, Wilson CB (1994) Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis. J Clin Invest 93:273–279CrossRef
14.
go back to reference Bricio T, Molina A, Mampaso F (1992) Effect of anti-interleukin-1 administration to rats with adriamycin-induced nephrosis. APMIS 100:401–407CrossRef Bricio T, Molina A, Mampaso F (1992) Effect of anti-interleukin-1 administration to rats with adriamycin-induced nephrosis. APMIS 100:401–407CrossRef
15.
go back to reference Le Hir M, Haas C, Marino M, Ryffel B (1998) Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice. Lab Invest 78:1625–1631PubMed Le Hir M, Haas C, Marino M, Ryffel B (1998) Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice. Lab Invest 78:1625–1631PubMed
16.
go back to reference Wu Y, Dong J, Yuan L, Liang C, Ren K, Zhang W, Fang F, Shen J (2008) Nephrin and podocin loss is prevented by mycophenolate mofetil in early experimental diabetic nephropathy. Cytokine 44:85–91CrossRef Wu Y, Dong J, Yuan L, Liang C, Ren K, Zhang W, Fang F, Shen J (2008) Nephrin and podocin loss is prevented by mycophenolate mofetil in early experimental diabetic nephropathy. Cytokine 44:85–91CrossRef
17.
go back to reference Hess J, Angel P, Schorpp-Kistner M (2004) AP-1 subunits: quarrel and harmony among siblings. J Cell Sci 117:5965–5973CrossRef Hess J, Angel P, Schorpp-Kistner M (2004) AP-1 subunits: quarrel and harmony among siblings. J Cell Sci 117:5965–5973CrossRef
18.
go back to reference Karin M, Chang L (2001) AP-1–glucocorticoid receptor crosstalk taken to a higher level. J Endocrinol 169:447–451CrossRef Karin M, Chang L (2001) AP-1–glucocorticoid receptor crosstalk taken to a higher level. J Endocrinol 169:447–451CrossRef
Metadata
Title
Protective effects of Huang Qi Huai granules on adriamycin nephrosis in rats
Authors
Chunhua Zhu
Songming Huang
Guixia Ding
Yanggang Yuan
Qiuxia Chen
Xiaoqin Pan
Ronghua Chen
Aihua Zhang
Publication date
01-06-2011
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 6/2011
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-011-1808-y

Other articles of this Issue 6/2011

Pediatric Nephrology 6/2011 Go to the issue

Educational Review

Intradialytic hypotension